What is the price target for MITO stock?
7 analysts have analysed MITO and the average price target is 1.81 USD. This implies a price increase of 465.78% is expected in the next year compared to the current price of 0.32.
STEALTH BIOTHERAPEUTICS CORP (MITO) Forecast, Price Target & Analyst Ratings
NASDAQ:MITO • US85789A1051
Current stock price
0.32 USD
0 (-1.36%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STEALTH BIOTHERAPEUTICS CORP (MITO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q2 / 2022
- EPS Estimate
- -$0.02
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$1.81
Upside
+ 465.78%
From current price of $0.32 to mean target of $1.81, Based on 7 analyst forecasts
Low
$1.52
Median
$1.81
High
$2.15
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for MITO. The average price target is 1.81 USD. This implies a price increase of 465.78% is expected in the next year compared to the current price of 0.32.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
MITO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MITO.
In the previous month the buy percentage consensus was at a similar level.
MITO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-01 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q2 / 2022
- EPS Estimate
- -$0.02
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 32.00%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2022 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.09M | 17.85M -100.00% | |||||||||
| EBITDA YoY % growth | -79.37M -28.97% | -74.97M 5.54% | -45.55M 39.24% | N/A -6.34% | N/A 4.57% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -79.72M -28.89% | -75.28M 5.57% | -45.83M 39.12% | -32.446M -6.20% | -47.092M 4.86% | -47.943M -3.54% | -47.377M 1.18% | -48.312M -1.97% | -47.177M 2.35% | -46.99M 0.40% | |
| Operating Margin | N/A | N/A | -217.31% | -181.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -0.15 88.04% | -0.06 26.67% | -0.31 27.27% | -0.06 23.50% | -0.05 16.67% | -0.06 -20.00% | -0.06 3.59% | -0.06 1.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 32.00% | -0.01 -2.00% | -0.01 66.00% | -0.01 -2.00% | -0.02 25.00% | -0.02 -50.00% | -0.01 | -0.02 -100.00% | -0.01 33.33% | -0.01 33.33% | -0.02 -100.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.73M -6.68% | -11.73M -2.48% | -11.73M 8.24% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.29%
EPS Next 5 Year
4.98%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
STEALTH BIOTHERAPEUTICS CORP / MITO Forecast FAQ
What are the consensus estimates for MITO stock next earnings?
The consensus EPS estimate for the next earnings of STEALTH BIOTHERAPEUTICS CORP (MITO) is -0.02 USD and the consensus revenue estimate is 0 USD.